- Home
- CMMB vs IHT Comparison
CMMB vs IHT Comparison
Compare CMMB & IHT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CMMB
- IHT
- Stock Information
- Founded
- CMMB 2004
- IHT 1971
- Country
- CMMB Israel
- IHT United States
- Employees
- CMMB N/A
- IHT N/A
- Industry
- CMMB Biotechnology: Pharmaceutical Preparations
- IHT Investment Bankers/Brokers/Service
- Sector
- CMMB Health Care
- IHT Finance
- Exchange
- CMMB Nasdaq
- IHT Nasdaq
- Market Cap
- CMMB 23.0M
- IHT 20.2M
- IPO Year
- CMMB N/A
- IHT N/A
- Fundamental
- Price
- CMMB $1.19
- IHT $2.27
- Analyst Decision
- CMMB Strong Buy
- IHT
- Analyst Count
- CMMB 2
- IHT 0
- Target Price
- CMMB $8.50
- IHT N/A
- AVG Volume (30 Days)
- CMMB 211.9K
- IHT 1.6K
- Earning Date
- CMMB 08-20-2025
- IHT 07-01-2025
- Dividend Yield
- CMMB N/A
- IHT 0.91%
- EPS Growth
- CMMB N/A
- IHT N/A
- EPS
- CMMB N/A
- IHT N/A
- Revenue
- CMMB N/A
- IHT $7,505,309.00
- Revenue This Year
- CMMB N/A
- IHT N/A
- Revenue Next Year
- CMMB N/A
- IHT N/A
- P/E Ratio
- CMMB N/A
- IHT N/A
- Revenue Growth
- CMMB N/A
- IHT N/A
- 52 Week Low
- CMMB $0.87
- IHT $1.34
- 52 Week High
- CMMB $2.55
- IHT $2.70
- Technical
- Relative Strength Index (RSI)
- CMMB 40.31
- IHT 44.42
- Support Level
- CMMB $1.17
- IHT $2.19
- Resistance Level
- CMMB $1.24
- IHT $2.35
- Average True Range (ATR)
- CMMB 0.07
- IHT 0.08
- MACD
- CMMB -0.01
- IHT 0.00
- Stochastic Oscillator
- CMMB 34.67
- IHT 68.00
About CMMB Chemomab Therapeutics Ltd.
Chemomab Therapeutics Ltd is a clinical-stage biotech company, focusing on the discovery and development of therapeutics for fibrosis-related diseases with large unmet needs. The company's candidate, CM-101, is a monoclonal antibody that targets CCL24 and was shown to interfere with the underlying biology of liver, skin, and lung fibrosis using a novel and differentiated mechanism of action. CM-101 has demonstrated the potential to treat multiple severe and life-threatening fibrotic and inflammatory diseases. It is advancing three Phase 2 clinical trials in parallel for CM-101, treating rare fibrotic conditions.
About IHT InnSuites Hospitality Trust Shares of Beneficial Interest
InnSuites Hospitality Trust is a real estate investment trust. It is engaged in the ownership and operation of hotel properties. It owns and operates hotels, provides management services for hotels, and also provides trademark license services. The Trust is also involved in various operations incidental to the operation of hotels, such as the operation of restaurants, meeting/banquet room rentals, and the operation of a reservation system. It has one reportable segment Hotel Operations & Hotel Management Services.